| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |